Skip to content
Antibodies & Bispecifics
Antibody Platforms
Monoclonal Discovery
Bispecific Discovery
Optimization
TCR Mimics
Genetic Medicines
AI/ML
Cell Therapies
Partnering
Ecosystem Allies
About
Leadership
News and Events
Careers
Resources
Antibodies & Bispecifics
Antibody Platforms
Monoclonal Discovery
Bispecific Discovery
Optimization
TCR Mimics
Genetic Medicines
AI/ML
Cell Therapies
Partnering
Ecosystem Allies
About
Leadership
News and Events
Careers
Resources
Contact Us
Full resource library
Alloy Therapeutics resources all in one place
Modality
Solution
Type
Modality
Antibodies and Bispecifics
Cell Therapies
Genetic Medicines
TCR Mimics
Solution
Antibody Platforms
ASO Gene Knockdown
Bispecific Discovery
Monoclonal Discovery
Optimization
TCR Mimic
Type
Case Studies
Perspectives
Press Releases
Technical Notes
Webinars
Press Releases
Alloy Accelerates Mediar Timeline to the Clinic for Complex Fibrosis Targets
Learn more
Technical Notes
Accelerated Antibody Discovery for Complex Fibrosis Targets
Learn more
Press Releases
Tahoe Therapeutics and Alloy Therapeutics to Form Joint Venture and Develop First-in-Class Antibody-Drug Conjugates for Hard-to-Treat Cancers
Learn more
Press Releases
Swiss Rockets Group and Alloy Therapeutics Partner to Advance Radioligand Therapeutics in Oncology
Learn more
Press Releases
Alloy Therapeutics Appoints Christian Cobaugh, Ph.D., as CEO of Alloy Genetic Medicines
Learn more
Technical Notes
Leveraging Human Lambda Light Chains in Antibody Discovery
Learn more
Technical Notes
De-risking antibody discovery through comprehensive developability profiling
Learn more
Webinars
Webinar: Unlocking Smarter Antibody Selection Strategies
Learn more
Press Releases
Alloy Therapeutics Announces Acquisition of Spannerwerks, a Leading Provider of Drug Development Consulting Services
Learn more